share_log

Evercore ISI Group Downgrades Bionomics to In-Line, Lowers Price Target to $6

Evercore ISI Group Downgrades Bionomics to In-Line, Lowers Price Target to $6

永可 ISI 集團將生物體學降級為直線,降低目標價格至 6 美元
Benzinga Real-time News ·  2022/12/20 05:07

Evercore ISI Group analyst Joshua Schimmer downgrades Bionomics (NASDAQ:BNOX) from Outperform to In-Line and lowers the price target from $17 to $6.

Evercore ISI Group分析師Joshua Schimmer將Bionomics(納斯達克:BNOX)的評級從強於大盤下調至同線,並將目標價從17美元下調至6美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論